RG 7990

Drug Profile

RG 7990

Alternative Names: BITS 7201A; RG7990; RO 7040547

Latest Information Update: 05 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NovImmune SA
  • Developer Genentech; NovImmune SA
  • Class Antiasthmatics; Bispecific antibodies
  • Mechanism of Action Interleukin 13 modulators; Interleukin 17 modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Allergic asthma

Most Recent Events

  • 18 May 2018 Adverse events data from a phase I trial in Allergic asthma presented at the 114th International Conference of the American Thoracic Society (ATS-2018)
  • 14 Jun 2017 Genentech completes a phase I trial for Allergic asthma in USA (SC and IV) (NCT02748642)
  • 19 Apr 2016 Genentech plans a phase I trial for Allergic asthma in USA (SC and IV) (NCT02748642)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top